Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 11, 2022
Factors associated with infection events after chimeric antigen receptor T-cell therapy for relapsed or refractory multiple myelomaDian Zhou, Ying Wang, Hai Cheng, et al.
Frontiers in Oncology|July 1, 2021
An Analysis of Cardiac Disorders Associated With Chimeric Antigen Receptor T Cell Therapy in 126 Patients: A Single-Centre Retrospective StudyKunming Qi, Zhiling Yan, Hai Cheng, et al.
Frontiers in Immunology|November 15, 2021
Humanized Anti-CD19 CAR-T Cell Therapy and Sequential Allogeneic Hematopoietic Stem Cell Transplantation Achieved Long-Term Survival in Refractory and Relapsed B Lymphocytic Leukemia: A Retrospective Study of CAR-T Cell TherapyWei Chen, Yuhan Ma, Ziyuan Shen, et al.
The Journal of Clinical Investigation|October 17, 2022
IL-1β-dependent extravasation of preexisting lung-restricted autoantibodies during lung transplantation activates complement and mediates primary graft dysfunctionWenbin Yang, Emily Jeong Cerier, Félix L Núñez-Santana, et al.
Journal of Medicinal Chemistry|March 30, 2011
A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatmentQian Cai, Haiying Sun, Yuefeng Peng, et al.
Oncotargets and Therapy|June 18, 2016
Risk model in stage IB1-IIB cervical cancer with positive node after radical hysterectomyZhilan Chen, Kecheng Huang, Zhiyong Lu, et al.
Transplantation and Cellular Therapy|March 30, 2021
Efficacy and Safety of Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Immunoglobulin D Multiple MyelomaWei Chen, Ying Wang, Kunming Qi, et al.
Oncotarget|August 25, 2016
Early response to neoadjuvant chemotherapy can help predict long-term survival in patients with cervical cancerXiong Li, Kecheng Huang, Qinghua Zhang, et al.
The European Respiratory Journal|December 18, 2025
Exploring fibroblast activation protein as an early biomarker in chronic lung allograft dysfunctionYudai Miyashita, Taisuke Kaiho, Hideki Nagata, et al.
Scientific Reports|June 10, 2016
Prognostic risk model development and prospective validation among patients with cervical cancer stage IB2 to IIB submitted to neoadjuvant chemotherapyKecheng Huang, Haiying Sun, Xiong Li, et al.
Pageof 21